Capital World Investors Pulmonx Corp Transaction History

Capital World Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $36.6 Million - $73 Million	-2,611,000 Reduced 88.61%	335,500 $4.94 Million
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $4.06 Million - $6.84 Million	192,000 Added 6.97%	2,946,500 $73.1 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $7.34 Million - $9.07 Million	204,000 Added 8.0%	2,754,500 $99.1 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $56.1 Million - $71.5 Million	1,490,500 Added 140.61%	2,550,500 $113 Million
Q1 2021 May 14, 2021	BUY	$44.0 - $67.54 $16.7 Million - $25.7 Million	380,570 Added 56.01%	1,060,000 $48.5 Million

Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $26.7 Million - $46.9 Million	679,430 New	679,430 $46.9 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.